Grants

Defining the Tumor Intrinsic and Regional Landscape of Therapeutic RNA-Nanoparticle Transduction and Immune Activation Following Intravenous Administration in DIPG

2023 New Investigator Grant

John Ligon, University of Florida

Identifying and Targeting Developmental Vulnerabilities of Diffuse Midline Gliomas

2023 New Investigator Grant

Lily Keane, University College Cork

Immune Determinants of GD2 CAR T-Cell Activity in Patients with DIPG

2023 New Investigator Grant

Sneha Ramakrishna, Stanford University

Co-funded by Violet Foundation for pediatric brain cancer, Tough2gether Foundation

Reprogramming the Tumor Microenvironment in DIPG with Engineered iPSC-NK Cells to Improve Immunotherapy

2023 New Investigator Grant

Sandro Matosevic, Purdue University

Co-funded by Violet Foundation for pediatric brain cancer

Targeting Aberrant RNA Translation in DIPG

2023 New Investigator Grant

John Prensner, University of Michigan

Co-funded by Violet Foundation for pediatric brain cancer

C7R-GD2 CAR T-Cells for DMG: Clinical Trial of Dual Route Strategy

2023 Game Changer Grant

Bilal Omer, Baylor College of Medicine

Co-funded by Violet Foundation for pediatric brain cancer

Engineering Enhanced GD2 CAR T-Cells to Overcome DIPG Immune Resistance

2023 Game Changer Grant

Robbie Majzner, Dana Farber Cancer Institute

Co-funded by Violet Foundation for pediatric brain cancer, SoSo Strong Pediatric Brain Tumor Foundation

In Vivo Imaging of Diffuse Midline Gliomas

2023 Game Changer Grant

Pavithra Viswanath, University of California, San Francisco

Sabine Mueller

Co-funded by Violet Foundation for pediatric brain cancer

CLIA certified assays for plasma-based disease response monitoring in histone mutant gliomas

2023 Special Project Grant

Carl Koschmann, University of Michigan

Co-funded by In partnership with DDRFA

Deciphering Aberrant RNA Translation in DIPG

2023 Special Project Grant

John Prensner, University of Michigan

Co-funded by In partnership with DDRFA